Acquired von Willebrand Syndrome in Patients With an Axial Flow Left Ventricular Assist Device
Author(s) -
Anna L. Meyer,
D. Malehsa,
Christoph Bara,
Ulrich Budde,
Mark S. Slaughter,
Axel Haverich,
M. Strueber
Publication year - 2010
Publication title -
circulation heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 104
eISSN - 1941-3297
pISSN - 1941-3289
DOI - 10.1161/circheartfailure.109.877597
Subject(s) - medicine , hemostasis , von willebrand factor , ventricular assist device , platelet , cardiology , von willebrand disease , coagulation , heart transplantation , epinephrine , transplantation , surgery , gastroenterology , heart failure
Rotary blood pumps used as left ventricular assist devices (LVADs) allow for long-term support and may become suitable alternatives to heart transplantation. Effects of this technology on the coagulation system are not completely understood, leading to controversial anticoagulation protocols. Thus, we investigated the primary hemostasis in patients with chronic LVAD therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom